Squarepoint’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,700
Closed -$20K 2750
2022
Q3
$20K Sell
16,700
-23,658
-59% -$28.3K ﹤0.01% 2004
2022
Q2
$73K Sell
40,358
-215,383
-84% -$390K ﹤0.01% 1923
2022
Q1
$517K Buy
255,741
+193,245
+309% +$391K ﹤0.01% 1476
2021
Q4
$169K Sell
62,496
-88,595
-59% -$240K ﹤0.01% 2162
2021
Q3
$674K Buy
151,091
+6,022
+4% +$26.9K ﹤0.01% 1249
2021
Q2
$841K Buy
145,069
+74,148
+105% +$430K ﹤0.01% 1297
2021
Q1
$498K Sell
70,921
-41,936
-37% -$294K ﹤0.01% 1531
2020
Q4
$542K Buy
+112,857
New +$542K ﹤0.01% 1454
2020
Q2
Sell
-43,908
Closed -$279K 2536
2020
Q1
$279K Sell
43,908
-31,827
-42% -$202K 0.01% 1321
2019
Q4
$790K Sell
75,735
-217,109
-74% -$2.26M ﹤0.01% 1456
2019
Q3
$1.15M Buy
292,844
+251,881
+615% +$990K 0.01% 1108
2019
Q2
$609K Buy
40,963
+10,044
+32% +$149K 0.01% 1523
2019
Q1
$767K Sell
30,919
-48,066
-61% -$1.19M 0.01% 1230
2018
Q4
$1.42M Buy
78,985
+72,116
+1,050% +$1.3M 0.02% 786
2018
Q3
$202K Sell
6,869
-33,467
-83% -$984K ﹤0.01% 1764
2018
Q2
$1.83M Buy
40,336
+34,136
+551% +$1.55M 0.02% 668
2018
Q1
$327K Sell
6,200
-4,293
-41% -$226K 0.01% 1272
2017
Q4
$714K Buy
+10,493
New +$714K 0.01% 978
2017
Q3
Sell
-2,700
Closed -$253K 1954
2017
Q2
$253K Buy
+2,700
New +$253K 0.01% 1203
2017
Q1
Sell
-20,813
Closed -$925K 2010
2016
Q4
$925K Buy
20,813
+13,813
+197% +$614K 0.04% 540
2016
Q3
$252K Buy
+7,000
New +$252K 0.02% 806
2016
Q1
Sell
-16,000
Closed -$560K 1525
2015
Q4
$560K Buy
+16,000
New +$560K 0.06% 477